{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-004450","form_type":"8-K","ticker":"ZVRA","cik":"0001434647","company_name":"ZEVRA THERAPEUTICS, INC.","filed_at":"2023-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.964813+00:00","generated_at":"2026-06-19T00:38:48.048531+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"KemPharm changes name to Zevra Therapeutics; ticker to become ZVRA on March 1, 2023","bullets":["Name change effective February 21, 2023 via Delaware certificate of amendment.","Common stock ticker to change from KMPH to ZVRA on Nasdaq on or about March 1, 2023.","No shareholder vote required; rights of shareholders, creditors, and CUSIP unchanged.","Bylaws amended and restated to reflect new name; no other charter or bylaw changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-004450","json":"https://secwatch.observer/filing/0001437749-23-004450.json","markdown":"https://secwatch.observer/filing/0001437749-23-004450.md","text":"https://secwatch.observer/filing/0001437749-23-004450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923004450/0001437749-23-004450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923004450/kmph20230220_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T00:38:48.048531+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19d4fdbb1d4d4154d4288c99f8408fa93d527783","claim":"ZEVRA THERAPEUTICS, INC.: Amended and restated bylaws to reflect name change to Zevra Therapeutics, Inc (effective 2023-02-21).","evidence_excerpt":"The Company also amended and restated its amended and restated bylaws (the “Amended and Restated Bylaws”) effective on February 21, 2023, to reflect the Name Change.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923004450/0001437749-23-004450-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-02-21"}],"fact_type":"governance_change"},{"claim_id":"8c9cc509a003aca7a2b6621f44d8b4669e7aeb20","claim":"ZEVRA THERAPEUTICS, INC.: Changed corporate name to Zevra Therapeutics, Inc. via certificate of amendment to certificate of incorporation (effective 2023-02-21).","evidence_excerpt":"Effective February 21, 2023, KemPharm, Inc. (the “Company”) changed its corporate name to Zevra Therapeutics, Inc. (the “Name Change”) pursuant to a certificate of amendment to the Company’s certificate of incorporation (the “Charter Amendment”)","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923004450/0001437749-23-004450-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-02-21"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}